Skip to content

View Spec Sheet

open_in_new
  1. Shop all
  2. Polyclonal

SPC-994

MAP4K4 Antibody (pThr187)

Cannot supply to this region.

SKU:
SPC-994
Additional Names:
MAP4K4, HGK, HPK/GCK like kinase, Hepatocyte progenitor kinase like/germinal center kinase like kinase, KIAA0687, M4K4_HUMAN, MAPK/ERK kinase kinase kinase 4, MEK kinase kinase 4, MEKKK 4, Mitogen activated protein kinase kinase kinase kinase 4, Nck interacting kinase, NIK
Application:
WB, Microarray
Species Reactivity:
Human
Purification:
Affinity Purified
Storage Conditions:
-20[o]C
Supplier:
StressMarq Biosciences
Host:
Rabbit
Reactivities:
Human
ABP:
IMP-GEN-2015-06 < 10% Serum <100ml
Buffer:
PBS pH7.4, 50% glycerol, 0.025% Thimerosal
Immunogen:
A phospho-specific peptide corresponding to residues surrounding Thr187 of human MAP4K4 (AA184-190)
Uniprot:
O95819
Synonyms:
epididymis secretory protein Li 31;FLH21957;HEL-S-31;hepatocyte progenitor kinase-like/germinal center kinase-like kinase;HGK;HPK/GCK-like kinase HGK;MAPK/ERK kinase kinase kinase 4;MEK kinase kinase 4;MEKKK4;mitogen-activated protein kinase kinase kinase kinase 4;nck-interacting kinase;NIK;Ste20 group protein kinase HGK
Extra Details:
Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4), particularly in its phosphorylated form at threonine 187 (pThr187), is emerging as a key upstream regulator of stress-responsive signaling pathways in the nervous system. MAP4K4 activates the JNK (c-Jun N-terminal kinase) pathway, a critical mediator of neuronal apoptosis, inflammation, and synaptic remodeling-processes commonly disrupted in neurodegenerative diseases. Phosphorylation of MAP4K4 at Thr187 enhances its kinase activity, facilitating downstream phosphorylation of targets such as SMAD1 at Thr322. This interaction links MAP4K4 to TGF-B Beta signaling, which plays a dual role in neuroprotection and neurodegeneration depending on cellular context. Dysregulated MAP4K4 signaling has been implicated in neuroinflammatory responses, oxidative stress, and glial activation, contributing to the progression of disorders such as Alzheimer's disease, Parkinson's disease, and ALS. MAP4K4 also influences cytoskeletal dynamics and blood-brain barrier integrity, suggesting broader roles in neuronal structure and vascular health. Its activation under pathological conditions makes MAP4K4 (pThr187) a promising biomarker and therapeutic target for modulating stress-induced neurodegenerative cascades. As neuroscience increasingly focuses on kinase-driven signaling networks, MAP4K4 stands out as a critical molecular switch linking extracellular stress to intracellular degeneration. Targeting its phosphorylation state may offer novel strategies for halting or reversing neurodegenerative progression.
Shipping Conditions:
Blue Ice